ALEXANDREA BEDIRIAN: Open Payments
NPI 1629735287 · SOUTH LYON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 16 payments from 11 companies in 2025. Trend: 2023 $805 · 2024 $390 · 2025 $417
Food & beverage: $317Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $100 |
| UCB, Inc. | 2 | $73 |
| Organon LLC | 4 | $55 |
| PFIZER INC. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: TREMFYA, Bimzelx, VTAMA, CIBINQO, DUPIXENT, COSENTYX, NEMLUVIO, Zoryve.
Industry payments across MI — which companies pay providers there.
